Pharming Group N.V. | Ownership
Companies that own Pharming Group N.V.
Fidelity Management & Research Co.
25,522,237
4.41%
0
0%
07/31/2018
Polar Capital LLP
18,500,000
3.2%
10,500,000
0.06%
04/25/2018
FMR Co., Inc.
13,561,376
2.34%
13,561,376
3.2%
04/09/2018
AXA Investment Managers UK Ltd.
6,118,478
1.06%
-2,829,105
0.03%
02/28/2018
BlackRock Fund Advisors
5,294,318
0.91%
0
0%
09/06/2018
BlackRock Advisors (UK) Ltd.
1,146,588
0.2%
0
0%
09/06/2018
Russell Investments Ltd.
496,852
0.09%
496,852
0.01%
03/31/2018
SSgA Funds Management, Inc.
469,982
0.08%
274
0%
09/06/2018
Credit Suisse Gestión SGIIC SA
452,288
0.08%
452,288
0.04%
12/31/2017
Deutsche Asset Management (UK) Ltd. (Investment Management)
417,917
0.07%
0
0%
09/06/2018
| Address |
Darwinweg 24
Leiden Zuid-Holland 2333 CR
Netherlands
|
|
Employees
|
- |
| Website |
http://www.pharming.com |
| Updated |
07/08/2019 |
| Pharming Group NV is a holding company, which engages in the development of pharmaceutical products for the treatment of rare diseases and unmet medical needs. The firm offers RUCONEST which is a recombinant human C1-esterase inhibitor for the treatment of acute hereditary angioedema. It operates through the following geographical segments: the United States, Europe, and Rest of the World. |
